Loading…
Potent Antimicrobial Azoles: Synthesis, In Vitro and In Silico Study
: The increase in fungal infections, both systemic and invasive, is a major source of morbidity and mortality, particularly among immunocompromised people such as cancer patients and organ transplant recipients. Because of their strong therapeutic activity and excellent safety profiles, azole antifu...
Saved in:
Published in: | Antibiotics (Basel) 2024-11, Vol.13 (11), p.1044 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | : The increase in fungal infections, both systemic and invasive, is a major source of morbidity and mortality, particularly among immunocompromised people such as cancer patients and organ transplant recipients. Because of their strong therapeutic activity and excellent safety profiles, azole antifungals are currently the most extensively used systemic antifungal drugs. Antibacterial properties of various topical antifungals, such as oxiconazole, which features oxime ether functionality, were discovered, indicating an exciting prospect in antimicrobial chemotherapy.
: In this study, eleven new oxime ether derivatives with the azole scaffold (
-
) were synthesized and tested for their antimicrobial effects using the microdilution method to obtain broad-spectrum hits.
: Although the title compounds showed limited efficacy against
species, they proved highly effective against dermatophytes. Compounds
and
were the most potent derivatives against
and
, with minimum inhibitory concentration (MIC) values lower than those of the reference drug, griseofulvin. The MIC of
and
were 0.491 μg/mL and 0.619 μg/mL against
(MIC of griseofulvin: 2.52 μg/mL). The compounds were also tested against Gram-positive and Gram-negative bacteria. Briefly,
was the most active against
and
, with MIC values much better than that of ciprofloxacin (MIC of
= 1.56 μg/mL and 1.23 μg/mL, MIC of ciprofloxacin = 31.49 and 125.99 μg/mL, respectively). Molecular docking suggested a good fit in the active site of fungal lanosterol 14α-demethylase (CYP51) and bacterial FtsZ (Filamenting temperature-sensitive mutant Z) protein.
: As a result, the title compounds emerged as promising entities with broad antifungal and antibacterial effects, highlighting the utility of oxime ether function in the azole scaffold. |
---|---|
ISSN: | 2079-6382 2079-6382 |
DOI: | 10.3390/antibiotics13111044 |